Skip to main content
Hit enter to search or ESC to close
Close Search
Menu
MitoXcel™ Technology
MitoXcel™ AI
Pipeline
Media Center
Menu
News
Pulmatrix picked for reverse merger with anti-aging biotech weeks after Cullgen deal collapses
By
egalli
March 27, 2026
No Comments
Pulmatrix picked for reverse merger with anti-aging biotech weeks after Cullgen deal collapses
Previous Post
Greater lean-body-mass decline with tirzepatide than semaglutide in routine care revealed by body-composition digital phenotyping
Next Post
Pulmatrix and Eos merge to advance gerotherapeutics
Leave a Reply
Cancel Reply
You must be
logged in
to post a comment.
Close Menu
MitoXcel™ Technology
MitoXcel™ AI
Pipeline
Media Center
